Assessing Racial Disparities in HCV Infection and Care Outcomes in a Southern Urban Population.

Autor: McGonigle K; Tulane University School of Medicine, New Orleans, LA, USA. kmcgonig@tulane.edu., Carley T; Tulane University School of Medicine, New Orleans, LA, USA., Hoff C; Tulane University School of Medicine, New Orleans, LA, USA.
Jazyk: angličtina
Zdroj: Journal of racial and ethnic health disparities [J Racial Ethn Health Disparities] 2018 Oct; Vol. 5 (5), pp. 1052-1058. Date of Electronic Publication: 2017 Dec 29.
DOI: 10.1007/s40615-017-0453-y
Abstrakt: Objectives: This study assessed racial disparities in access to healthcare services, hepatitis C virus (HCV) exposure, and retention in a treatment cascade in two indigent populations in an urban center in the Southern US.
Participants/methods: Opt-in HCV antibody screening was offered at two large homeless centers and three residential substance abuse treatment centers (SATCs) in New Orleans, LA. Five hundred ninety-four participants experiencing homelessness and 342 residents of SATCs were assessed for previous access/perceived barriers to healthcare services and high-risk behaviors associated with HCV exposure. Participants were then screened using rapid HCV antibody testing and tracked through a treatment cascade involving referral to a primary care provider (PCP), RNA confirmation, and specialist referral.
Results: In both the homeless and SATC populations, whites were more likely to report barriers to accessing healthcare and high-risk behaviors, especially prior intravenous drug use (IVDU). Interaction between age and race demonstrates a protective effect of white ethnicity at higher ages, at a level approaching statistical significance. Non-whites were equally likely to access follow-up care and treatment as whites.
Conclusions: Despite many more risk factors reported by the white population, HCV antibody positivity was largely equal between the two racial groups. Known interactions between race and age in the African American population were demonstrated in these high-risk, urban populations. Whites were no more likely to achieve various levels of a treatment and care cascade. The results may demonstrate the impact of improved access to testing services and primary care, although access to treatment remains a significant barrier to eliminating racial disparities in HCV infection.
Databáze: MEDLINE
Externí odkaz: